Antiviral therapy against HIV infection.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 2193956.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The replication of human immunodeficiency virus (HIV) can be suppressed in vivo by drugs chosen on the basis of their selective in vitro antiviral activity. Such suppression can confer prolonged survival and improved quality of life in patients with already established HIV infection. The clinical benefits indicate that targeted therapy for acquired immunodeficiency syndrome based on the emerging knowledge of replicative cycle of HIV is an attainable goal.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Antiviral Agents
- HIV Infections